Compound ID | 3409
Ribaxamase
Synonym(s): SYN-004 | SYN004 | SYN 004
Class: Microbiome modulating agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Clostridioides difficile; indicated for C. difficile infection; prevents dysbiosis |
| Description: | Beta-lactamase enzyme delivered orally to degrade beta-lactams in gastrointestinal tracts of patients undergoing antibiotic treatment for Clostridium difficile infection |
| Institute where first reported: | Theriva Biologics |
| Year first mentioned: | 2016 |
| Highest developmental phase: | Phase 2 |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.